Avidity Biosciences
Open
$12.72
Prev. Close
$12.72
High
$12.79
Low
$12.72
Market Snapshot
$205.26M
-2.90
$10.9M
511
Atrium Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in San Diego, California and currently employs 47 full-time employees. The company went IPO on 2026-02-27.
emptyResult
Atrium Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in San Diego, California and currently employs 47 full-time employees. The company went IPO on 2026-02-27.
Recently from Cashu
Avidity Biosciences Adjusts Stockholder Meeting for Novartis Merger and Distribution Timeline
Avidity Biosciences Gears Up for Strategic Merger and Stock Distribution Avidity Biosciences, Inc. announces a pivotal update regarding its special meeting of stockholders, originally set for February…
Avidity Biosciences Pursues Merger with Novartis and Atrium Stock Distribution Plan
Avidity Biosciences Advances Towards Major Merger and Stock Distribution Avidity Biosciences, Inc. confirms its commitment to enhancing shareholder value through a strategic merger with Novartis AG an…
Lilac and Soin seek RNA biomarkers for spinal cord stimulation; Avidity Biosciences (RNA) cited
Objective molecular readouts for spinal cord stimulation take shape PROVIDENCE/ DAYTON — Lilac Biosciences and Soin Neuroscience are launching a preclinical collaboration to test whether RNA expressio…
Lilac–Soin pursue RNA biomarkers to objectify spinal cord stimulation pain; implications for Avidity Biosciences
RNA readouts aim to objectify pain response Lilac Biosciences is partnering with Soin Neuroscience to test whether changes in RNA expression can serve as reproducible molecular signatures of response…